HEAD & NECK CANCERS
Latest News
October 8th 2024
The KEYNOTE-689 study evaluating pembrolizumab in this patient population met its primary end point of event-free survival.
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
More News
Women With Head and Neck Cancer May Be Severely Undertreated Compared With Men
June 2nd 2018According to study results presented at the 2018 ASCO Annual Meeting, women with head and neck cancer (HNC) are less likely to recieve intensive chemotherapy and radiation when compared with their male counterparts.
Read More
Tracking System Helps Reduce Symptom Severity in Head and Neck Cancers
May 17th 2018In results of a large randomized trial of patients with head and neck cancer who had undergone radiation therapy, patients who used mobile and sensor technology to track their symptoms demonstrated reduced severity of their symptoms compared with patients who received standard care.
Read More
